GREY:IPHAF - Post by User
Comment by
labumbaon Mar 10, 2009 1:13pm
342 Views
Post# 15833624
RE: trial extensions
RE: trial extensionsTCDrug, you sound very pessimistic.......I still believe this is a " plateform " drug of the future cause nothing indicates that this drug is inferior to any immunosuppressive drugs in the market according to the trial results of the past. Atrium and Lux are still testing Voclo in full swing....
Here is a fact that Voclo has a potency ratio 3:1 in comparing with Cyclosporin and the chronic nephrotoxicity numbers of the last trial will settle the score. One also should look at safety profile of 0.4 mg/kg in the Essence trial and it did speak for itself